Mundipharma: Swissmedic reviewing licence extension for the SGLT2 inhibitor Invokana® (canagliflozin) in fast-track procedure

World News: . []

Mundipharma welcomes the news that Swissmedic the Swiss Agency for Therapeutic LINK  the surveillance authority for medicines and LINK  devices in Switzerland is conducting a fast-track review of Mundipharma Switzerlands application to ex tend ma...

More news and information about Mundipharma

Published By:

Business Wire: 00:01 GMT Thursday 10th October 2019

Published: .

Search for other references to "mundipharma" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2020. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us